NAD Nasal Spray in Oakland: What the Research Shows

NAD nasal spray is a compounded intranasal preparation of nicotinamide adenine dinucleotide, a coenzyme central to mitochondrial energy production and DNA repair. Oakland readers searching for it tend to be longevity-curious adults asking whether a delivery route designed to bypass first-pass metabolism does anything that oral NAD precursors don't already do. The published human evidence is thinner than the marketing implies.

Across the Bay Area — from biotech offices to climbing gyms in Emeryville — interest in NAD nasal spray in Oakland tracks a wider longevity question: can you slow the cellular fatigue that accumulates after 35? This article walks through what NAD does, what controlled trials have measured, and how clinicians evaluate candidates.

What NAD+ does — and why levels matter

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It cycles between oxidized (NAD+) and reduced (NADH) forms as it shuttles electrons through the electron transport chain — the final step in how mitochondria convert food into ATP, the cell's energy currency.

NAD+ is also a substrate for three families of enzymes that depend on it:

• Sirtuins (SIRT1–SIRT7), which regulate gene expression, stress response, and metabolic adaptation
• PARPs (poly-ADP-ribose polymerases), which repair DNA damage
• CD38, a NAD-consuming enzyme upregulated in aging tissue and chronic inflammation

Tissue NAD+ concentrations decline with age. A study of human skin found roughly a 50% drop between young adulthood and the seventh decade (Massudi et al., PLoS One 2012), with parallel findings in skeletal muscle and brain. Whether replenishing NAD+ in older adults reverses functional outcomes — energy, recovery, cognition — is the question every clinical trial in this space is currently trying to answer.

What controlled human trials have actually measured

Most rigorous human research on raising NAD+ uses oral precursors, not intranasal NAD itself. The two most studied are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).

A six-week randomized trial of NR (1,000 mg/day) in healthy middle-aged and older adults raised whole-blood NAD+ levels by approximately 60% versus placebo and was well-tolerated, though the study was not powered to show changes in performance or longevity endpoints (Martens et al., Nat Commun 2018). A 10-week NMN trial in prediabetic postmenopausal women showed improved muscle insulin sensitivity but no change in body weight or other metabolic markers (Yoshino et al., Science 2021).

Reviewing the broader literature, Covarrubias and colleagues concluded that NAD-boosting compounds "robustly elevate NAD+ in tissues" but that downstream functional benefits in humans remain "an active area of investigation" (Covarrubias et al., Nat Rev Mol Cell Biol 2021). A separate review in Cell Metabolism reached a similar verdict: pharmacology promising, mechanistic story coherent, randomized human outcomes still maturing (Rajman et al., Cell Metab 2018).

The relevant point for an Oakland reader: NAD repletion via oral precursors has reasonably consistent biomarker evidence. Intranasal NAD itself has not been the subject of comparable randomized human trials in the published literature. That doesn't mean it doesn't work; it means the evidence base is currently inferential rather than direct.

Why the intranasal route — and what it actually does

The nasal mucosa has dense vascularization and a thin epithelial barrier, which is why intranasal drug delivery can produce rapid systemic absorption (think sumatriptan for migraine, or naloxone for opioid overdose reversal). The nasal route also bypasses hepatic first-pass metabolism, which can degrade certain orally administered compounds before they reach circulation.

Whether NAD itself crosses the nasal mucosa intact and meaningfully elevates intracellular NAD+ pools — versus being enzymatically broken down to nicotinamide and other precursors before it gets anywhere — is a question that, candidly, has not been answered in published, peer-reviewed human pharmacokinetic data at the time of this writing. Compounded intranasal NAD preparations are typically formulated at concentrations chosen by the prescribing clinician based on individual patient factors, not against a single FDA-approved label.

The intellectually honest framing is this: nasal delivery is a plausible route for systemic small-molecule absorption, NAD biology is well-characterized, and the bridge between those two facts — direct human PK and outcome data for compounded intranasal NAD — is still being built. A patient considering it should know that going in.

How an Oakland clinician evaluates a NAD nasal spray candidate

A licensed clinician reviewing a request for the clinician-evaluated NAD+ nasal program at Body Good Men typically thinks about:

• Goal alignment. What is the patient hoping to address — energy, post-workout recovery, sleep quality, cognitive sharpness, post-illness rebound? Are those goals plausibly downstream of an NAD-targeted intervention, or better served by addressing sleep, training load, or another evaluation entirely?
• Medical history. Chronic conditions, current medications (especially those metabolized through pathways that NAD intersects with), nasal anatomy, history of sinus disease or rhinitis.
• Realistic expectations. A clinician will reset expectations away from "dramatic transformation" and toward "modest, individualized, often subjective changes" — and will set a follow-up window to assess whether continuation is warranted.
• Alternatives. Whether oral NAD precursors, the NAD+ injectable program at Body Good Men, or the NAD+ topical cream might be a better fit given the patient's profile and goals.

A clinician will not start a patient on a compounded NAD product as a substitute for evaluating an undiagnosed symptom — chronic fatigue, persistent brain fog, unintentional weight loss — that warrants a proper workup.

Questions worth bringing to your provider

If you're going to a telehealth visit (or an in-person appointment in Oakland) to discuss NAD supplementation, useful questions include:

• Given my history and what I'm hoping to address, is NAD repletion a reasonable approach — and is there a route (oral, intranasal, injectable) you'd prefer for me?
• What outcomes should I look for over the first four to eight weeks, and at what point do we agree to stop if I'm not noticing change?
• Are there interactions with medications or supplements I'm currently on?
• How will we track tolerability — local nasal irritation, headaches, anything systemic?

The goal isn't to walk in asking for a specific product. It's to understand whether the clinical reasoning fits.

Common misconceptions

"Nasal delivery works faster than oral, so it's better." Faster onset doesn't necessarily mean greater intracellular NAD elevation or better functional outcomes. Different routes have different pharmacokinetic profiles, and "best" depends on what the clinician and patient are trying to accomplish.

"NAD reverses aging." No published human trial has shown this, full stop. The longevity case for NAD precursors rests on biomarker data, animal studies, and mechanistic plausibility. Those are real, but they are not the same as outcome data in older humans.

"If it's compounded, it's basically the same as a brand-name supplement." Compounded preparations are distinct from any FDA-approved drug or commercially marketed dietary supplement. They are individualized formulations prepared by a licensed pharmacy under a clinician's prescription.

Frequently asked questions

Is NAD nasal spray FDA-approved?

NAD nasal spray is not an FDA-approved drug for any specific indication. It is typically prepared as a compounded preparation by a licensed pharmacy under a clinician's prescription. That means there is no single approved label, no required Phase III efficacy trial, and no manufacturer-funded post-marketing surveillance. A licensed clinician determines whether a compounded preparation is appropriate for an individual patient.

How does NAD nasal spray differ from NAD IV therapy?

NAD IV therapy delivers NAD directly into the bloodstream and is typically administered in a clinic over several hours; intranasal delivery uses the nasal mucosa for absorption and is self-administered at home. The two routes have different pharmacokinetics, different cost and time profiles, and different evidence bases. Neither has been compared head-to-head in a peer-reviewed randomized trial for functional outcomes.

What does the research actually show for NAD supplementation?

Randomized trials of oral NAD precursors (nicotinamide riboside and nicotinamide mononucleotide) have consistently raised blood NAD+ levels with reasonable safety in studied populations (Martens et al., Nat Commun 2018; Yoshino et al., Science 2021). Functional outcomes — energy, performance, longevity — are still being investigated. Direct human trials of intranasal NAD itself remain sparse in the peer-reviewed literature.

Is NAD nasal spray safe for most adults?

Reported tolerability for compounded NAD products is generally good in clinical use, with local nasal irritation, mild headache, or transient flushing among the more common complaints. Safety in pregnancy, in adults with active sinus disease, and in combination with certain medications has not been adequately studied. A clinician's evaluation is the right place to address individual risk before starting.

Talking to a clinician

If you're considering NAD+ supplementation and want to know whether it's appropriate for you, talk to a licensed clinician. The NAD+ Nasal program at Body Good Men connects you with a US-licensed clinician who reviews your eligibility and, if appropriate, prescribes through our partner pharmacy.

Important Disclosure

men.joinbodygood.com is operated as an affiliate of Body Good Studio LLC and is a whitelabel certified partner of Leg Up Rx. men.joinbodygood.com does not provide medical services, prescribe medications, or maintain patient records. All clinical evaluations, prescription decisions, and medication fulfillment are handled by licensed medical and pharmacy partners through Leg Up Rx. This article is for general informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting any treatment. Eligibility for any medication is determined solely by a licensed clinician.